Alopecia News

Poor representation of darker skin tones in dermatology training materials has led to delayed diagnoses and worse treatment outcomes in Black, Asian and non-white Latin American patients, according to a presenter.

Healio has compiled July’s most-read news in dermatology.

The FDA has approved Leqselvi 8 mg tablets to treat severe alopecia areata in adults, Sun Pharma announced in a press release.

While the art of tattooing has been present for centuries, the medical implications are only recently coming to light with modern medicine.

Healio has compiled June’s most-read news in dermatology.

Makeup not only has cosmetic applications, but medical ones too.

The first participant has been enrolled in Eirion Therapeutics’ phase 1 study evaluating the safety of ET-02 for the treatment of androgenic alopecia, the company announced in a press release.

Women who use contraceptive pills may be at a higher risk for frontal fibrosing alopecia, according to a study.

Equillium announced positive topline data from its phase 2, single-dose, proof-of-concept study of EQ101 for the treatment of adults with moderate, severe or very severe alopecia areata, according to a press release.

Soterios Pharma has announced positive topline results from its phase 2 trial evaluating STS-01 for the treatment of mild to moderate alopecia areata, according to a company press release.